BBOT NASDAQ
BridgeBio Oncology Therapeutics Inc.
1W: +7.0%
1M: +2.7%
3M: -8.7%
YTD: -25.9%
$8.55
-0.56 (-6.15%)
Weekly Expected Move ±7.7%
$7
$8
$9
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$684.9M
52W Range7.6-14.87
Volume737,080
Avg Volume336,882
Beta0.19
Dividend—
Analyst Ratings
Company Info
CEOEli Wallace
Employees62
SectorHealthcare
IndustryBiotechnology
IPO Date2025-08-12
Websitebbotx.com
256 E. Grand Avenue
South San Francisco, CA 94080
US
South San Francisco, CA 94080
US
650 405 4770
About BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors. Initially formed as a subsidiary of BridgeBio Pharma, it focuses on precision oncology with a pipeline that includes BBO-8520, BBO-10203, and BBO-11818 programs targeting KRAS and PI3K pathways. The company recently went public through a business combination with Helix Acquisition Corp. II, raising approximately $450 million to advance clinical development. The CEO is Dr. Eli Wallace, and the CSO is Dr. Pedro Beltran.
Latest News
BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress
BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress
12 Health Care Stocks Moving In Monday's Pre-Market Session
BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026
BridgeBio Oncology Therapeutics appoints new CEO and COO
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Elmelech Idan | A-Award | 758,222 | $7.66 | 2026-05-10 |
| Beltran Pedro | A-Award | 1,103,837 | $7.66 | 2026-05-10 |
| Cobo Marc | 0 | — | 2026-04-21 | |
| Cobo Marc | 129,090 | $9.59 | 2026-04-21 | |
| Cobo Marc | 25,125 | $10.19 | 2026-04-21 |